CCL5 is a member of a large family of proteins responsible for immune cell migration toward disease sites. The work upon this molecule suggests that CCL5 and/or related proteins may lead to fresh therapies that help the immune system resist TB. Related StoriesStudy reveals mechanism behind protein-related diseasesMyriad RBM's DiscoveryMAP system identifies protein biomarkers linked to CV events in diabetes patientsUnderstanding how schizophrenia affects workings of the brain We hope this research will spark curiosity in understanding the mechanisms which control cell migration to sites of infection, help define the protective immune response to Mycobacterium tuberculosis, and ultimately improve our capacity to predict and/or treat patients with TB, said Gillian Beamer, V.M.D, Dipl.Of the virus offers all but dry out also. Don’t hype it, simply report it Attkisson stated on the program that infectious disease professionals remain very concerned, because if the deadly virus gets out of control in the United States, we won’t even have the ability to, obviously, cope with it. The public now could be somewhat safer, she told sponsor Howard Kurtz, but the reason for that is because there was media insurance and a public outcry that transformed completely how the authorities managed the Ebola crisis. Attkisson also said that she phoned the CDC lately to inquire about just how many potential cases were getting actively monitored in the U.S., and was informed that 1,400 people were being implemented.